Get In Touch

Global Drug Discovery Technologies Market: Overview

Due to the prevalence of several life-threatening diseases and frequent inception of new health-related issues, it is essential to discover new, advanced, efficient drugs to combat the illness. Healthcare organizations across the world are actively looking for opportunities for drug discovery, which was historically done through identification of active ingredient from traditional remedies. However, in the recent past, the field of drug discovery has evolved considerably with technologies such as mass spectrometry, NMR, micro plate readers, chemotherapy, proteomics (2DGE, two hybrid systems, isotope encoding and activity based assays), RANi (siRNA, miRNA, ddRNAi, and short hairpin RNAs), microfluidics, gel electrophoresis, protein and nucleic acid isolation, DNA and protein microarrays, and nanotechnology, which includes atomic force microscopy, nano mass spectroscopy, and dip pen nanolithography. Drug discovery process have now become more refined and accurate, as well as significantly less time consuming.

It has been observed that high-throughput screening (HTS) is one of the most widely used drug discovery technologies. Through this technology, a large number of potential biological modulators are assayed against a chosen set of defined targets. HTS technology enables building a portfolio of biologically relevant compounds quickly. Advancement in HTS technology such as reliable automation, multidetector readers, imaging hardware and software, and database and pattern recognition software will lead to the increased usage of the technology in future.

Drug discovery technologies play a major role in overall growth of the pharmaceutical industry because they significantly contribute to the easy introduction of blockbusters and innovative drugs. Diverse diseases such as cancer, CVD and CNS disorders such as Parkinson’s and Alzheimer’s have generated ample opportunities in the market for drug discovery technologies, which is estimated for a healthy growth rate during the forecast period of 2016–2024.

Global Drug Discovery Technologies Market: Trends and Opportunities

The market is primarily driven by rising geriatric population across the globe as people aged over 60 years are more prone to chronic diseases. The demand for efficient drugs, especially from the rising population of affluent patients, is another factor pushing the global market for drug discovery technologies. Moreover, advances in the fields of biotechnology, molecular biology, nanotechnology, and genomics in the recent past have also paved way for increased investments in the field of drug discovery. Furthermore, patent expiries of several blockbuster drugs during the forecast period are also expected to make it a lucrative market for the existing players. New pharmaceutical companies also have an opportunity to venture into the global market for drug discovery technologies through generics.

As drug discovery plays an important role in the drug development cycle, pharmaceutical companies focus more on drug development technologies. However, drug discovery and development requires a huge investment and takes a long time, which leads to lower profit margins for the pharmaceutical companies. Pharmaceutical manufacturers usually face an impending surge of expiring patents regarding developed drugs, exacerbating the adverse effects of the long duration of the research cycle. This could hinder the market’s growth in the coming years.

Global Drug Discovery Technologies Market: Region-wise Outlook

Geographically, the global market for drug discovery technologies can be segmented into the regions of North America, Europe, Asia Pacific, and Rest of the World. Currently, North America is the most lucrative market due to high concentration of world’s leading pharmaceutical companies. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America also gains from high-income population, collectively promising healthy potential returns on investments due to high adoption rate of new technologies. Asia Pacific holds immense promise as a market for drug discovery technologies due to rising disposable incomes, favorable long-term government policies, and aggressive investment by pharmaceutical industry in the region, which has skilled labor at affordable cost.

Companies mentioned in the research report

Some of the key players in the global drug discovery technologies market are Abbott Laboratories, Inc., Affymetrix Inc., Agilent Technologies, Inc., Bayer Healthcare AG, GE Healthcare Ltd., Albany Molecular Research Inc., Arqule Inc., Astrazeneca plc, Novartis AG, Luminex Corporation, and Molecular Discovery Ltd. Many of the key players are partnering to develop sophisticated drug discovery technologies and discover novel drugs for various ailments.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Drug Discovery Technologies

Pre Book